Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults

Cardiovascular Diabetology

Majed S Alokail³  George P Chrousos¹  Abdulrahman Al-Ajlan²  Shaun Sabico³  Abdullah M Alnaami³  Kaiser Wani³  Omar S Al-Attas³  Nasser M Al-Daghri³ 

[1] First Department of Pediatrics, Athens University Medical School, Athens, 11527, Greece;Department of Clinical Lab Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia;Prince Mutaib Bin Abdullah Chair on Osteoporosis, Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Kingdom of Saudi Arabia

关键词: Arabs;    Cardiometabolic diseases;    DMT2;    Body adiposity index;    Visceral adiposity index;   

Others  :  1223753
DOI  :  10.1186/s12933-015-0265-5

 received in 2015-05-28, accepted in 2015-07-29,  发布年份 2015

【 摘 要 】

Background

Obesity is a recognized risk factor for various cardiometabolic diseases and several indices are used clinically to assess overall cardiometabolic risk. This study aims to determine the sensitivity of six anthropometric indices [Body mass index (BMI), waist, waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), body adiposity index (BAI) and visceral adiposity index (VAI)] in determining diabetes mellitus type 2, coronary heart disease, dyslipidemia, hypertension and metabolic syndrome (MetS) in Saudi adults recruited from two independent cohorts (2008–2009 and 2013–2014).

Methods

A total of 6,821 Saudi adults [2008–2009, N = 3,971 (1,698 males and 2,273 females); 2013–2014, N = 2,850 (926 males and 1,924 females)] aged 18–70 years old were included in this descriptive, cross-sectional study. Anthropometrics were obtained and fasting blood samples analyzed for glucose and lipids. BMI, WHR, WHtR, BAI and VAI were computed mathematically.

Results

VAI was the most sensitive index in determining DMT2 (AUC 0.72; p < 0.001) in the 2008–2009 cohort and MetS (AUC = 0.84; p < 0.001) in the 2013–2014 cohort. WHR was most discriminating for CHD in both cohorts (AUC 0.70 and 0.84 for 2008–2009 and 2013–2014, p values <0.001, respectively). WHtR was most sensitive but rather modest in determining hypertension (AUC 0.66; p < 0.001), while waist circumference was most sensitive for dyslipidemia (AUC 0.72; p < 0.001) in the 2008–2009 cohort and MetS (AUC 0.85; p < 0.001) in the 2013–2014 cohort. BAI was the least sensitive adiposity index.

Conclusion

Sensitivity of adiposity indices regarding cardiometabolic diseases highlight the importance of body fat distribution in determining overall cardiometabolic risk, with indices involving abdominal obesity being more clinically significant than BMI and BAI. The sensitivity of these adiposity indices should be noted in assessing a particular cardiometabolic disease.

【 授权许可】

   
2015 Al-Daghri et al.

【 图 表 】

Fig.1.

【 参考文献 】

• [1]Morgen CS, Sorensen TI. Obesity: global trends in the prevalence of overweight and obesity. Nat Rev Endocrinol. 2014; 10(9):513-514.
• [2]Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C et al.. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Diseases Study in 2013. Lancet. 2014; 384(9945):766-781.
• [3]Al-Quwaidhi AJ, Pearce MS, Critchley JA, Sobngwi E, O’Flaherty M. Trends and future projections of the prevalence of adult obesity in Saudi Arabia, 1992–2022. East Mediterr Health J. 2014; 20(10):589-595.
• [4]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL et al.. Diabetes Mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011; 9:76. BioMed Central Full Text
• [5]Lim RB, Chen C, Naidoo N, Gay G, Tang WE, Seah D et al (2015) Anthropometrics indices of obesity, and all-cause and cardiovascular disease-related mortality, in an Asian cohort with type 2 diabetes mellitus. Diabetes Metab [Epub ahead of print]
• [6]Czernichow S, Kengne AP, Huzley RR, Butley GD, de Galan B, Grobbee D et al.. Comparison of waist-hip ratio and other obesity indices as predictors of cardiovascular disease risk in people with type 2 diabetes: a prospective cohort study from ADVANCE. Eur J Cardiovasc Prev Rehabil. 2011; 18(2):312-319.
• [7]Cronin O, Morris DR, Walker PJ, Golledge J. The association of obesity with cardiovascular events in patients with peripheral artery disease. Atherosclerosis. 2013; 228(2):316-323.
• [8]Bergman RN, Stefanovski D, Buchanan TA, Summer AE, Reynolds JC, Sebring NG et al (2011) A better index of body adiposity. Obesity (Silver Spring) 19(5):1083–1089
• [9]Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M et al.. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33(4):920-922.
• [10]Djibo DA, Araneta MR, Kritz-Silverstein D, Barrett-Connor E, Wooten W. Body adiposity index is a risk factor for the metabolic syndrome in postmenopausal Caucasian African American, and Filipina women. Diabetes Metab Syndr. 2015; 9(2):108-113.
• [11]Garcia AI, Nino-Silva LA, Gonzalez-Ruiz K, Ramirez-Velez R. Body adiposity index as a marker of obesity and cardiovascular risk in adults from Bogota, Colombia. Endocrinol Nutr. 2015; 62(3):130-137.
• [12]Yu Y, Wang L, Liu H, Zhang S, Walker SO, Bartell T et al.. Body mass index and waist circumference rather than body adiposity index are better surrogates for body adiposity in a Chinese population. Nutr Clin Pract. 2015; 30(2):274-282.
• [13]Amato MC, Giordano C. Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol. 2014; 2014:730827.
• [14]Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Charalampidis P, Livadas S et al.. Visceral adiposity index is highly associated with adiponectin and glycaemic disturbances. Eur J Clin Invest. 2013; 43(2):183-189.
• [15]Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.
• [16]Al-Daghri N, Alokail M, Al-Attas O, Sabico S, Kumar S. Establishing abdominal height cut-offs and their association with conventional indices of obesity among Arab children and adolescents. Ann Saudi Med. 2010; 30(3):209-214.
• [17]Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 Suppl 1:S62-S69.
• [18]Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003; 42:1206-1252.
• [19]Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-2497.
• [20]Alberti KG, Zimmet P, Shaw J. IDF epidemiology task force consensus group. The metabolic syndrome: a new worldwide definition. Lancet. 2005; 366:1059-1062.
• [21]Amato MC, Pizzolanti G, Torregrossa V, Misiano G, Milano S et al.. Visceral adiposity index is predictive of an altered adipokine profile in patients with type 2 diabetes. PLoS One. 2014; 9(3):e91969.
• [22]Amato MC, Giordano C. Clinical indications and proper use of Visceral Adiposity Index. Nutr Metab Cardiovasc Dis. 2013; 23:e31-e32.
• [23]Han L, Fu KL, Zhao J, Wang ZH, Tang MX, Wang J et al.. Visceral adiposity index score indicated the severity of coronary heart disease in Chinese adults. Diabetol Metab Syndr. 2014; 6(1):143. BioMed Central Full Text
• [24]Mousavi SV, Mohebi R, Mozaffary A, Sheikholeslami F, Azizi F, Hadaegh F (2014) Changes in body mass index, waist and hip circumference, waist to hip ratio and risk for all-cause mortality in men. Eur J Clin Nutr [Epub ahead of print]
• [25]Myint PK, Kwok CS, Luben RN, Wareham NJ, Khaw KT. Body fat percentage, body mass index and waist-to-hip ratio as predictors of mortality and cardiovascular disease. Heart. 2014; 100(20):1613-1619.
• [26]De Koning L, Merchant AT, Pogie J, Anand SS. Waist circumference and waist-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007; 28(7):850-856.
• [27]Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82864 participants from nine cohort studies. Obes Rev. 2011; 1299:680-687.
• [28]Lukich A, Gavish D, Shargorodsky M. Normal weight diabetic patients versus obese diabetics: relation of over-all and abdominal adiposity to vascular health. Cardiovasc Diabetol. 2014; 13:141. BioMed Central Full Text
• [29]Lam BC, Koh GC, Chen C, Wong MT, Fallows SJ. Comparison of body mass index (BMI), body adiposity index (BAI), waist circumference (WC), waist-to-hip ratio (WHR) and waist-to-height-ratio as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS One. 2015; 10(4):e0122985.
• [30]Ashwell M, Gunn P, Gibson S. Waist-to-Height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012; 13(3):275-286.
• [31]Li WC, Chen IC, Chang YC, Loke SS, Wang SH, Hsiao KY. Waist-to-Height ratio, waist circumference, and body mass index as indices of cardiometabolic risk among 36,642 Taiwanese adults. Eur J Nutr. 2013; 52(1):57-65.
• [32]Park YS, Kim JS. Association between waist-to-height ratio and metabolic risk factors in Korean adults with normal body mass index and waist circumference. Tohoku J Exp Med. 2012; 228(1):1-8.
• [33]Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014; 13(1):146. BioMed Central Full Text
• [34]Zafrir B, Khashper A, Gaspar T, Dobrecky-Mery I, Azencot M, Lewis BS et al (2014) Prognostic impact of abdominal fat distribution and cardiorespiratory fitness in asymptomatic type 2 diabetics. Eur J Prev Cardiol [Epub ahead of print]
• [35]Nagao H, Kashine S, Nishizawa H, Okada T, Kimura T, Hirata A et al.. Vascular complications and changes in body mass index in Japanese type 2 diabetic patients with abdominal obesity. Cardiovasc Diabetol. 2013; 12:88. BioMed Central Full Text
• [36]Chandra A, Neeland IJ, Berry JD, Ayers CR, Rohatgi A, Das SR et al.. The relationship of body mass index and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol. 2014; 64(10):997-1002.
• [37]Farb MG, Gokce N. Visceral adiposopathy: a vascular perspective. Horm Mol Biol Clin Investig. 2015; 21(2):125-136.
• [38]Shah RV, Murthy VL, Abbasi SA, Blankstein R, Kwong RY, Goldfine AB et al.. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. JACC Cardiovasc Imaging. 2014; 7(12):1221-1235.
• [39]Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A, Devlin AM. Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol. 2013; 12:170. BioMed Central Full Text